Letzte Zahlen 4. Aug. 2026
Bayer AG NA
I · KI-Analyse
Kurzfassung
Bayer makes prescription medicines for heart disease, women's health, cancer, and blood disorders; sells consumer brands like Midol and Aspirin; and provides seeds, pesticides, and digital farming tools to agriculture customers worldwide [Yahoo Finance]. The Crop Science division is the largest profit contributor, generating nearly half of total revenue [Simply Wall St].
Bayer is a 161-year-old German life sciences giant operating three major divisions: prescription drugs (Pharmaceuticals), over-the-counter health products (Consumer Health), and agricultural seeds and crop chemicals (Crop Science) [Yahoo Finance]. The company currently reports a €2,2 billion net loss on €45,6 billion in revenue, but recent news signals potential recovery through two FDA priority-review drugs in stroke prevention and lung cancer [Yahoo Finance]. Bayer also faces ongoing environmental liabilities, including a recent $133 million settlement for PCB contamination cleanup [Seeking Alpha].
Bayer is currently unprofitable with moderate debt levels, but maintains strong gross margins and positive free cash flow [Yahoo Finance].
Sentinellis-Score
4,2/10
Erhebliche Risiken
Marktkapitalisierung
EUR 37,8B
Umsatz (12 Monate)
EUR 45,6B
Erklärt
Wie wir diese Zahlen lesen
Verständliche Leitfäden · ohne Konto
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LesenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LesenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LesenII · Aktuelle Nachrichten
Was den Kurs bewegt hat
6 Meldungen · nach Relevanz sortiert
- Makro2026-05-20
BAYRY or RHHBY: Which Is the Better Value Stock Right Now?
Zacks
- Makro2026-05-20
Should FDA Priority Review for HYRNUO’s First-Line Lung Cancer Use Require Action From Bayer (XTRA:BAYN) Investors?
Yahoo Finance
- Makro2026-05-19
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
Yahoo Finance
- Makro2026-05-19
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
Yahoo Finance
- Makro2026-05-19
FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC
Yahoo Finance
- Makro2026-05-17
Assessing Bayer (XTRA:BAYN) Valuation After Mixed Share Performance And Profit Recovery Hopes
Simply Wall St
Premium · kostenlos mit jedem Konto
Bayer reported a €2,2 billion net loss for the most recent fiscal year despite €45,6 billion in revenue, and the company remains unprofitable with a negative net margin of -7,9% [Yahoo Finance]
Risiken
5
Chancen
5
Warnsignale
3
Führung
10
12 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.
Vollständige Bayer AG NA-Analyse freischalten
Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.
- 5 Risiken, 5 Chancen und 3 Warnsignale — jeweils mit Quelle
- Über 100 Finanzkennzahlen mit Charts und Vergleichen
- Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
- Führungsteam und Vergütung
III · Ähnliche Unternehmen
Das könnte Sie auch interessieren
Gleicher Sektor · Gesundheitswesen — oder vergleichbare Finanzlage
Auf Ihre Watchlist setzen?